Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by barcodewhizon Dec 14, 2004 6:30pm
281 Views
Post# 8313570

this news is simply not factored in

this news is simply not factored in Obviously the market was expecting this news, it was certainly telegraphed by management. HOWEVER, dont for a minute think that this stock is appropriately priced at a $1.77 just because we didnt gap up on these results. Frankly, I think the announcement was a little short on details despite the fact that the message was clearly delivered. They said in no uncertain terms that the results are "comparable" to EPO. THAT IS HUGE no matter how you slice it. Because of the difficult last couple of years in this stock, we're all feeling overly cautious and scratching our heads. REST ASSURED, these results are a very big deal. These kinds of results simply dont come along every day. The company is keeping the details close to their chest, probably because they're trying to advance negotiations with one or more suitors. Prometic is holding the cards and the big boys are interested. When we wake up to the news of a significant deal on 1402, which could realistically happen any day in the next week, month, quarter.... the stock wont be $1.80 offerred and people selling today will be feeling quite short sighted.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse